Evotec SE
Company Profile
Business description
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Contact
Essener Bogen 7
Manfred Eigen Campus
Hamburg 22419
DEUT: +49 40560810
E: werner.lanthaler@evotec.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2024
Employees
5,055
Stocks News & Analysis
stocks
Going into earnings, Is Apple stock a buy, a sell, or fairly valued?
stocks
One of the hottest shares on the ASX reports strong growth
stocks
Diverging value in Australia's real estate sector
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,153.40 | 59.10 | 0.73% |
| CAC 40 | 7,517.68 | 90.66 | 1.22% |
| DAX 40 | 18,417.55 | 118.83 | 0.65% |
| Dow JONES (US) | 40,589.34 | 654.27 | 1.64% |
| FTSE 100 | 8,285.71 | 99.36 | 1.21% |
| HKSE | 17,021.31 | 16.34 | 0.10% |
| NASDAQ | 17,357.88 | 176.16 | 1.03% |
| Nikkei 225 | 37,667.41 | 202.10 | -0.53% |
| NZX 50 Index | 12,349.47 | 46.80 | -0.38% |
| S&P 500 | 5,459.10 | 59.88 | 1.11% |
| S&P/ASX 200 | 7,921.30 | 60.10 | 0.76% |
| SSE Composite Index | 2,890.90 | 4.16 | 0.14% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Bellevue Gold Ltd BGL | 1.44 | 0.40 | -21.58% |
| Argosy Minerals Ltd AGY | 0.05 | 0.01 | 41.18% |
| Red 5 Ltd RED | 0.38 | 0.02 | -5.06% |
| Pilbara Minerals Ltd PLS | 2.98 | 0.11 | 3.83% |
| Droneshield Ltd DRO | 1.40 | 0.09 | -6.04% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Core Lithium Ltd CXO | 0.10 | 0.01 | 6.59% |
| Zip Co Ltd ZIP | 1.78 | 0.04 | -1.93% |
| South32 Ltd S32 | 2.98 | 0.07 | 2.41% |
| Telstra Group Ltd TLS | 3.85 | 0.01 | 0.26% |